SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
The Neuroscientist
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1073858408331376v1
15/4/317    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Coulson, E.J.
Right arrow Articles by Hamlin, A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coulson, E.J.
Right arrow Articles by Hamlin, A.S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Alzheimer's Disease
Genetics Home Reference
*Genetics Home Reference - Alzheimer disease
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Role of the p75 Neurotrophin Receptor in Cholinergic Dysfunction in Alzheimer's Disease

E.J. Coulson

Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia, e.coulson{at}uq.edu.au

L.M. May

Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia

A.M. Sykes

Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia

A.S. Hamlin

Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia

Degeneration of basal forebrain cholinergic neurons is a common feature of Alzheimer's disease and is proposed to be an early and key event in the condition's etiology. This review discusses recent findings that strongly link the p75 neurotrophin receptor (p75 NTR) to both cholinergic neuron degeneration and the production of toxic forms of amyloid-beta (Aß), which is found deposited as amyloid plaques in the brains of Alzheimer's disease patients. Although elucidating the underlying molecular mechanisms and the clinical significance of these findings will require further experimentation, a number of possible scenarios and future research directions are presented.

Key Words: Alzheimer's disease • basal forebrain cholinergic neuron • neurotrophins • transgenic mouse models • neurodegeneration

This version was published on August 1, 2009

The Neuroscientist, Vol. 15, No. 4, 317-323 (2009)
DOI: 10.1177/1073858408331376


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?